Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1971 1
1972 2
1973 6
1974 4
1975 23
1976 43
1977 52
1978 77
1979 89
1980 153
1981 162
1982 178
1983 219
1984 284
1985 285
1986 331
1987 322
1988 353
1989 389
1990 447
1991 382
1992 472
1993 596
1994 617
1995 586
1996 639
1997 686
1998 812
1999 808
2000 957
2001 1003
2002 1000
2003 1016
2004 1092
2005 1207
2006 1185
2007 1183
2008 1126
2009 1102
2010 1176
2011 1173
2012 1119
2013 1225
2014 1208
2015 1180
2016 1159
2017 1135
2018 1113
2019 1078
2020 1120
2021 1113
2022 960
2023 938
2024 405

Text availability

Article attribute

Article type

Publication date

Search Results

33,252 results

Results by year

Filters applied: . Clear all
Page 1
Tamoxifen versus clomiphene citrate for ovulation induction in infertile women.
Jie L, Li D, Yang C, Haiying Z. Jie L, et al. Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:57-64. doi: 10.1016/j.ejogrb.2018.06.022. Epub 2018 Jun 12. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29909264 Review.
This systematic review aimed to compare the clinical efficacy of tamoxifen with that of clomiphene citrate (CC) in anovulatory patients. ...There were no statistically significant differences for the ovulation and pregnancy rates in the tamoxifen comparing to …
This systematic review aimed to compare the clinical efficacy of tamoxifen with that of clomiphene citrate (CC) in anovulatory …
Tamoxifen citrate: a glimmer of hope for silicosis.
Yoldas O, Karaca T, Bilgin BC, Yilmaz OH, Simsek GG, Alici IO, Uzdogan A, Karaca N, Akin T, Yoldas S, Akbiyik F. Yoldas O, et al. J Surg Res. 2015 Jan;193(1):429-34. doi: 10.1016/j.jss.2014.08.013. Epub 2014 Aug 14. J Surg Res. 2015. PMID: 25218282
BACKGROUND: Inhalation of crystalline silica nanoparticles causes pulmonary damage resulting in progressive lung fibrosis. Currently, there is no effective treatment for silicosis. Tamoxifen citrate is a selective estrogen receptor modulator, which is one of the adj …
BACKGROUND: Inhalation of crystalline silica nanoparticles causes pulmonary damage resulting in progressive lung fibrosis. Currently, there …
Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
Ravikumara NR, Bharadwaj M, Madhusudhan B. Ravikumara NR, et al. J Biomater Appl. 2016 Nov;31(5):755-772. doi: 10.1177/0885328216670561. Epub 2016 Sep 22. J Biomater Appl. 2016. PMID: 27664187
In vitro studies for cytotoxicity, DNA ladder, and the expression of Bcl-2-Bax expression were also investigated for MCF-7 and MDA-MB-231 cells after the addition of tamoxifen citrate alone and tamoxifen citrate-poly(d,l) lactic acid-nanoparticles (enc …
In vitro studies for cytotoxicity, DNA ladder, and the expression of Bcl-2-Bax expression were also investigated for MCF-7 and MDA-MB-231 ce …
Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase.
Ismail A, Mokhlis HA, Sharaky M, Sobhy MH, Hassanein SS, Doghish AS, Salama SA, Mariee AD, Attia YM. Ismail A, et al. Pathol Res Pract. 2022 Dec;240:154211. doi: 10.1016/j.prp.2022.154211. Epub 2022 Nov 11. Pathol Res Pract. 2022. PMID: 36401980
Lipid metabolic reprogramming is involved in mediating tamoxifen (TAM) response in breast cancer cells. Published microarray data indicated that ATP citrate lyase (ACLY) is overexpressed in TAM-resistant BC cells. ...
Lipid metabolic reprogramming is involved in mediating tamoxifen (TAM) response in breast cancer cells. Published microarray data ind …
Does tamoxifen citrate prevent pulmonary fibrosis due to silica inhalation?
Karaca T, Yoldas O, Bilgin BC, Yilmaz OH, Karaca N, Simsek GG, Alici IO, Uzdogan A, Tezer A, Comert MA, Akin T, Kismet K, Tutkun E, Akbiyik F. Karaca T, et al. Bratisl Lek Listy. 2015;116(7):440-5. doi: 10.4149/bll_2015_083. Bratisl Lek Listy. 2015. PMID: 26286247
We investigated the possible preventive effect of tamoxifen in rats exposed to silica particles depending on the antifibrotic effect. ...Tamoxifen is found to prevent lung fibrosis and reduce serum TGFbeta-1 levels while increasing lung inflammation (Tab. 3, Fig. 3, …
We investigated the possible preventive effect of tamoxifen in rats exposed to silica particles depending on the antifibrotic effect. …
Tamoxifen citrate loaded ethosomes for transdermal drug delivery system: preparation and characterization.
Sarwa KK, Suresh PK, Debnath M, Ahmad MZ. Sarwa KK, et al. Curr Drug Deliv. 2013 Aug;10(4):466-76. doi: 10.2174/1567201811310040011. Curr Drug Deliv. 2013. PMID: 23656399
Long term tamoxifen citrate therapy is imperative to treat several dermatological and hormonal sensitive disorders. ...In the present work, tamoxifen citrate loaded ethosomes were prepared and characterized for transdermal applications. ...
Long term tamoxifen citrate therapy is imperative to treat several dermatological and hormonal sensitive disorders. ...In the …
Tamoxifen.
Long K, Long R. Long K, et al. Nurse Pract Forum. 1993 Jun;4(2):72-3. Nurse Pract Forum. 1993. PMID: 8513266 No abstract available.
Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: development, characterisation and in-vitro cell viability study.
Kathle PK, Gautam N, Kesavan K. Kathle PK, et al. J Microencapsul. 2018 May;35(3):292-300. doi: 10.1080/02652048.2018.1477844. Epub 2018 Jun 8. J Microencapsul. 2018. PMID: 29771175
The objective of this study was to evaluate the potential of chitosan-gellan nanocapsules (CGNCs) for encapsulation and sustained release of Tamoxifen citrate (TMC) for breast cancer therapy. Polyelectrolyte complex coacervation method was used for production of CGN …
The objective of this study was to evaluate the potential of chitosan-gellan nanocapsules (CGNCs) for encapsulation and sustained release of …
Tamoxifen-induced uterine abnormalities: the role of imaging.
Ascher SM, Imaoka I, Lage JM. Ascher SM, et al. Radiology. 2000 Jan;214(1):29-38. doi: 10.1148/radiology.214.1.r00ja4429. Radiology. 2000. PMID: 10644098 Review.
Tamoxifen citrate is an orally administered, nonsteroidal antiestrogen agent that is widely used for the treatment of breast cancer and that has recently been found to prevent breast cancer in some high-risk populations. Tamoxifen may, however, cause adverse …
Tamoxifen citrate is an orally administered, nonsteroidal antiestrogen agent that is widely used for the treatment of breast c …
An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N, Hiremath JG, Chilukuri S, Aitha RK, Al-Dhubiab BE, Venugopala KN, Alzahrani AM, Meravanige G. SreeHarsha N, et al. Biomed Res Int. 2019 Jan 20;2019:2161348. doi: 10.1155/2019/2161348. eCollection 2019. Biomed Res Int. 2019. PMID: 30800663 Free PMC article.
We tested the solubility and dissolution of tamoxifen citrate to ascertain the optimal conditions for faster dissolution. Using the solvent evaporation method and hydrophilic carriers, we formulated tamoxifen citrate (TC) that contained solid dispersio …
We tested the solubility and dissolution of tamoxifen citrate to ascertain the optimal conditions for faster dissolution. Usin …
33,252 results
You have reached the last available page of results. Please see the User Guide for more information.